[go: up one dir, main page]

BG102809A - Vaccine against the reproductive and respiratory syndrome in pigs - Google Patents

Vaccine against the reproductive and respiratory syndrome in pigs

Info

Publication number
BG102809A
BG102809A BG102809A BG10280998A BG102809A BG 102809 A BG102809 A BG 102809A BG 102809 A BG102809 A BG 102809A BG 10280998 A BG10280998 A BG 10280998A BG 102809 A BG102809 A BG 102809A
Authority
BG
Bulgaria
Prior art keywords
reproductive
pigs
respiratory syndrome
vaccine against
vaccine
Prior art date
Application number
BG102809A
Other languages
Bulgarian (bg)
Other versions
BG64693B1 (en
Inventor
Richard Hesse
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24442410&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG102809(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of BG102809A publication Critical patent/BG102809A/en
Publication of BG64693B1 publication Critical patent/BG64693B1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)

Abstract

The invention relates to a vaccine and methods for thetreatment of the reproductive and respiratory syndrome in pigs.The vaccine is produced from the NEB-1-P94 viral agent depositedin the American collection of types of cultures under No. VR-2525.The invention also relates to vaccinal virus of phenotypecharacteristics by which it can be distinguished from the PRRSwild type virus.9 claims
BG102809A 1996-03-01 1998-09-29 Vaccine against the reproductive and respiratory syndrome in pigs BG64693B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60980696A 1996-03-01 1996-03-01

Publications (2)

Publication Number Publication Date
BG102809A true BG102809A (en) 1999-05-31
BG64693B1 BG64693B1 (en) 2005-12-30

Family

ID=24442410

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102809A BG64693B1 (en) 1996-03-01 1998-09-29 Vaccine against the reproductive and respiratory syndrome in pigs

Country Status (19)

Country Link
EP (1) EP0894007A1 (en)
JP (1) JP3135069B2 (en)
KR (1) KR100297537B1 (en)
CN (1) CN1165342C (en)
AR (1) AR006023A1 (en)
AU (1) AU2277497A (en)
BG (1) BG64693B1 (en)
BR (1) BR9708443B1 (en)
CA (1) CA2248182C (en)
CO (1) CO4600644A1 (en)
CZ (1) CZ273798A3 (en)
EE (1) EE04741B1 (en)
HU (1) HUP9901958A3 (en)
MY (1) MY115070A (en)
PL (1) PL328627A1 (en)
RU (1) RU2187333C2 (en)
SK (1) SK119498A3 (en)
WO (1) WO1997031651A1 (en)
ZA (1) ZA971663B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0839912A1 (en) 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
CA2440933A1 (en) 1998-12-22 2000-06-22 Pfizer Products Inc. An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
EP1157121B1 (en) 1999-03-08 2013-04-24 Boehringer Ingelheim Vetmedica GmbH Prrsv replicon
JP4778620B2 (en) 1999-04-22 2011-09-21 ユナイテッド ステイツ デパートメント オブ アグリカルチャー Pig breeding / breathing disorder syndrome vaccine based on isolate JA-142
EP1781327A4 (en) 2004-06-18 2009-02-25 Univ Minnesota IDENTIFICATION OF VIRAL INFECTION ORGANISMS AND VACCINES
US7632636B2 (en) 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
PL2369001T3 (en) 2005-06-24 2017-06-30 Regents Of The University Of Minnesota PRRS viruses, infectious clones, mutants thereof, and methods of use
RU2354333C1 (en) * 2007-07-24 2009-05-10 ФГОУ ВПО Омский государственный аграрный университет Method for early diagnostics of postnatal diseases in sows
CN101612395B (en) * 2008-06-24 2012-02-08 扬州优邦生物制药有限公司 Method for producing blue-ear disease vaccine by culturing sensitive cell
TWI627281B (en) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 Methods of reducing viricidal activity in pcv-2 compositions and pcv-2 compositions with an improved immunogenicity
UA117272C2 (en) 2011-02-17 2018-07-10 Бьорінгер Інгельхайм Ветмедіка Гмбх NEW EUROPEAN PRRSV STRAIN
CN103370077B (en) 2011-02-17 2016-10-26 贝林格尔.英格海姆维特梅迪卡有限公司 Process for commercial scale production of porcine reproductive and respiratory syndrome virus
WO2013017568A1 (en) 2011-07-29 2013-02-07 Boehringer Ingelheim Vetmedica Gmbh INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF
US9187731B2 (en) 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
KR101300528B1 (en) * 2011-10-05 2013-09-02 캔 테크놀로지스 인코포레이티드 Composition for prevention and treatment of Actinobacillus pleuropneumoniae infection
CN105073130A (en) 2013-03-15 2015-11-18 勃林格殷格翰动物保健公司 Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
EP4012025A1 (en) * 2020-12-10 2022-06-15 Univerzita Palackého v Olomouci Transport medium for samples containing nucleic acids and/or proteins
CZ309704B6 (en) * 2020-12-10 2023-08-09 Univerzita Palackého v Olomouci Transport medium for virus transport and storage

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6042830A (en) * 1992-08-05 2000-03-28 Boehringer Ingelheim Vetmedica, Inc. Viral agent associated with mystery swine disease
HU220113B (en) * 1991-10-14 2001-11-28 Akzo N.V. Porcine reproductive respiratory syndrome vaccine, process for producton and use thereof
FR2686097B1 (en) * 1992-01-14 1994-12-30 Rhone Merieux PREPARATION OF ANTIGENS AND MYSTERY DISEASE VIRUS VACCINES, ANTIGENS AND VACCINES OBTAINED FOR THE PREVENTION OF THIS DISEASE.
US5695766A (en) * 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
DE69426228T2 (en) * 1993-02-08 2001-03-01 Bayer Ag Method of propagating the swine virus causing reproductive and respiratory syndrome and using it as a vaccine.
ES2074950B1 (en) 1993-09-17 1996-03-16 Iberica Cyanamid VACCINE FOR THE PREVENTION OF REPRODUCTIVE AND RESPIRATORY DISEASE OF THE SOW.
DE69522984T2 (en) * 1994-04-11 2002-04-25 Akzo Nobel Nv Pig reproductive respiratory syndrome virus vaccine European strains
US5690940A (en) * 1995-06-21 1997-11-25 Regents Of The University Of Minnesota Low pathogencity PRRS live virus vaccines and methods of preparation thereof

Also Published As

Publication number Publication date
EP0894007A1 (en) 1999-02-03
EE04741B1 (en) 2006-12-15
CA2248182A1 (en) 1997-09-04
CZ273798A3 (en) 1999-02-17
HUP9901958A2 (en) 1999-10-28
KR19990087432A (en) 1999-12-27
JPH11506122A (en) 1999-06-02
BR9708443B1 (en) 2012-06-12
JP3135069B2 (en) 2001-02-13
ZA971663B (en) 1997-08-26
SK119498A3 (en) 1999-07-12
MX9807083A (en) 1998-12-31
CA2248182C (en) 2004-04-20
AU2277497A (en) 1997-09-16
WO1997031651A1 (en) 1997-09-04
MY115070A (en) 2003-03-31
KR100297537B1 (en) 2001-10-26
BR9708443A (en) 1999-08-03
AR006023A1 (en) 1999-07-21
RU2187333C2 (en) 2002-08-20
PL328627A1 (en) 1999-02-15
CN1216922A (en) 1999-05-19
EE9800267A (en) 1999-02-15
HUP9901958A3 (en) 2000-04-28
BG64693B1 (en) 2005-12-30
CO4600644A1 (en) 1998-05-08
CN1165342C (en) 2004-09-08

Similar Documents

Publication Publication Date Title
BG102809A (en) Vaccine against the reproductive and respiratory syndrome in pigs
BG100974A (en) Vaccines against papillomavirus
DE69619233D1 (en) Prrs-(porcine reproductive and respiratory syndrome)-virusvakzin
ES2074950A1 (en) Viral vaccine for the prevention of porcine reproductive and respiratory syndrome
MY113428A (en) Hepatitis b vaccine
HUP9903169A3 (en) Low pathogenicity prrs live virus vaccines and methods of preparation thereof
DE69734284D1 (en) COMPOSITION OF A POLYNUCLEOTIDE VACCINE FOR THE TREATMENT OF RESPIRATORY AND REPRODUCTIVE DISEASES OF THE PIG
ATE199022T1 (en) EUROPEAN VACCINE STRAINS OF SWINE REPRODUCTIVE-RESPIRATORY SYNDROME VIRUS (PRRSV)
DE69426228D1 (en) Method of propagating the swine virus causing reproductive and respiratory syndrome and using it as a vaccine.
ZA9510832B (en) Variants of human papilloma virus antigens
PT835133E (en) Recombinant poxvirus-rabies compositions and combination compositions and uses
HU9302484D0 (en) Dissoluble ligands for cd-40
HUT57264A (en) Process for producing turkey- recombinant herpes virus and living vector vaccine from them
EP1852121A3 (en) Lipid analogs for treating viral infections
PL336714A1 (en) Antigen loci prrsv identifying the peptidic sequences of prrs virus for use in vaccines or diagnostic tests
CA2076744A1 (en) Viral Agent Associated with Mystery Swine Disease
RU96119986A (en) VACCINE FOR PIG PREVENTION FROM RESPIRATORY OR REPRODUCTIVE DISEASES CONTAINING PARAGRIPPOUS VIRUSES
UA40571C2 (en) COW HERPES VIRUS MUTANT TYPE 1 (BHV-1), VACCINE COMPOSITION FOR VACCINATION OF ANIMALS FOR THEIR PROTECTION AGAINST BHV-1, COMPOSITION OF VACCINATION
NL300402I1 (en) Method and manufacture of an acellular vaccine comprising Bordetella pertussis antigens
ATE274579T1 (en) MULTIVALENT VACCINE AGAINST BOVINE CORONAVIRUS AND METHOD FOR TREATING BOVINE CORONAVIRUS INFECTION
CA2116355A1 (en) Infectious bovine rhinotracheitis virus mutants and vaccines
SE9400524L (en) energy Preparations
HU906509D0 (en) Process for producing vaccine against virus of infecting bronchitis
ZA964094B (en) Compositions and methods for the diagnosis of and vaccination against hepatitis c virus (hcv)
DE3279264D1 (en) Method of immunizing pigs against aujeszky's disease